Venturi Wealth Management LLC Sells 762 Shares of Exelon Co. (NASDAQ:EXC)

Venturi Wealth Management LLC lessened its position in shares of Exelon Co. (NASDAQ:EXCFree Report) by 41.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,083 shares of the company’s stock after selling 762 shares during the quarter. Venturi Wealth Management LLC’s holdings in Exelon were worth $44,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Exelon by 16.3% during the 1st quarter. Vanguard Group Inc. now owns 105,310,761 shares of the company’s stock valued at $3,956,525,000 after buying an additional 14,749,899 shares in the last quarter. Lazard Asset Management LLC boosted its holdings in shares of Exelon by 112.4% in the 1st quarter. Lazard Asset Management LLC now owns 31,527,396 shares of the company’s stock worth $1,184,483,000 after purchasing an additional 16,686,526 shares during the period. Jacobs Levy Equity Management Inc. increased its position in shares of Exelon by 2.4% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 4,887,035 shares of the company’s stock valued at $183,606,000 after purchasing an additional 113,428 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its holdings in Exelon by 4.6% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 4,374,891 shares of the company’s stock valued at $164,623,000 after buying an additional 193,223 shares during the period. Finally, Los Angeles Capital Management LLC lifted its position in Exelon by 666.2% in the second quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company’s stock worth $124,024,000 after buying an additional 3,115,763 shares during the last quarter. Institutional investors own 80.92% of the company’s stock.

Exelon Trading Up 2.6 %

Shares of NASDAQ EXC opened at $39.11 on Friday. Exelon Co. has a 1-year low of $33.35 and a 1-year high of $41.42. The business has a fifty day moving average price of $39.68 and a 200 day moving average price of $37.79. The stock has a market capitalization of $39.30 billion, a P/E ratio of 16.09, a price-to-earnings-growth ratio of 2.72 and a beta of 0.54. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97.

Exelon (NASDAQ:EXCGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The business had revenue of $6.15 billion for the quarter, compared to analysts’ expectations of $5.85 billion. During the same period last year, the business earned $0.67 EPS. The company’s revenue was up 2.9% compared to the same quarter last year. Equities research analysts expect that Exelon Co. will post 2.45 EPS for the current fiscal year.

Exelon Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 11th will be given a $0.38 dividend. The ex-dividend date is Friday, November 8th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.89%. Exelon’s payout ratio is 62.55%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on EXC. Barclays raised their target price on shares of Exelon from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. Wells Fargo & Company upped their target price on Exelon from $40.00 to $42.00 and gave the company an “equal weight” rating in a research note on Friday, August 2nd. Scotiabank raised their price target on Exelon from $37.00 to $40.00 and gave the stock a “sector perform” rating in a research note on Tuesday, August 20th. UBS Group upped their price objective on Exelon from $40.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, September 20th. Finally, Morgan Stanley lifted their target price on Exelon from $42.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Wednesday, September 25th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $41.33.

View Our Latest Stock Analysis on EXC

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.